EnWave Signs R&D Agreement with Nestlé – the Largest Food Company in the World
EnWave Corp’s (TSXV:ENW – $1.03 CAD & OTC:NWVCF – $0.74 USD & Frankfurt:E4U – €0.74) Radiant Energy Vacuum (REV) technology has once again attracted the attention of a world class company, Nestlé.
The two companies have signed a Technology Evaluation and License Option Agreement (TELOA) that gives Nestlé the opportunity to evaluate EnWave’s REV technology for the dehydration of a number of specific products.
Headquartered in Switzerland, Nestlé SA is the largest food company in the world, measured by revenues. It even ranked No. 33 on the 2016 edition of the Forbes Global 2000 list of largest public companies.
Nestlé’s products include baby food, medical food, bottled water, breakfast cereals, coffee and tea, confectionery, dairy products, ice cream, frozen food, pet foods, and snacks. Twenty-nine of its brands have annual sales of over CHF1 billion (about US$1.04 billion), including Nespresso, Nescafé, Kit Kat, Smarties, Nesquik, Stouffer’s, Vittel, and Maggi. Nestlé has 447 factories, operates in 194 countries, and employs around 339,000 people worldwide.
EnWave and Nestlé signed a previous R&D agreement back in 2010, which didn’t mature. However, it is worth noting that this new deal concerns a completely different product area. This project is being handled by a new team on both companies’ end. Moreover, EnWave is better positioned now than it was seven years ago to deliver commercial scale machinery.
Additional Tests on the Way
EnWave and Nestlé have been in touch for about a year discussing applications in this particular product category. During that time, EnWave produced multiple samples for analysis, which were reviewed very favorably by Nestlé. This positive outcome resulted in a formal TELOA to further refine the unique product area.
Further testing is scheduled to take place at EnWave’s facility in the next twelve months. Nestlé has the option to exclusively license the REV technology for specific product types given that the testing period avails favourably.
Conclusion
Lots of work has already been completed the past twelve months to develop specific product applications, which compelled Nestlé to engage in a formal R&D project.
Currently, EnWave is advancing dozens of prospective royalty partners in the dairy, meat, fruit, and vegetable markets that are conducting initial testing and product development under Technology Evaluation and License Option Agreements. With each additional TELOA, which has the potential to gradually evolve into a commercial agreement, EnWave’s already solid foundation is growing.
Although agreements with large companies such as Nestlé typically take some time to develop, their potential is enormous. Recommendation BUY.
| For important disclosures, please read our disclaimer. | Latest Company Report (pdf) | |
Questions were asked elsewhere…What become of the prior TELOA Enwave had with Nestle? Do we know what is bringing them back to the table?
Hi Buhlz_I,
You have come to the right place to get some answers. 🙂
The R&D agreement that was signed in 2010 didn’t mature.
As for what brings Nestlé back to table, I guess that it continues to see the potential value of REV. Also, EnWave, as a company, as well as its technology, have obviously much advanced compared with 2010. In addition, it is important to stress that this new deal concerns a completely different product area than in 2010, and this project is being handled by a new team on both companies’ end.
I hope this helps.
Cheers,
John
John,
Excellent coverage on Enwave. This technology is very powerful. I have used it in the pharmaceutical industry, known as “freeze drying”. Enwave is making practical applications of it for widespread commercial use. Yes, the food industry will certainly be a widespread user.
Always look forward to each edition of Smallcaps. So stimulating!
Chris